An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

Whether it’s allergies, a sinus infection or runny nose many people turn to nasal sprays for quick relief. And now, there’s ...

NTx’s new services offering provides faster and more affordable high-integrity, complex mRNA production powered by NTxscribe® ...

At the Pondy Lit Fest 2024, an insightful discussion took place on the future of mRNA technology in malaria vaccine ...

A German study published in July 2024 did not find that mRNA COVID-19 vaccines damaged children’s immune systems, contrary to ...

With considerable investments in research and development, Moderna, Inc. (NASDAQ:MRNA) is well-positioned to take advantage ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Low serum sodium concentrations in the blood are called hyponatremia, a prevalent clinical electrolyte disorder. In contrast ...

Moderna’s recent stock drop reflects investor concerns over the company’s revised financial outlook and strategic shifts. Despite its pioneering role in mRNA technology and promising future prospects, ...

About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we ...

Proteolipid vehicles merge directly with the cell membrane, skipping a pathway that traps many DNA and RNA therapies.

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season.